Pour quelle procédure opter dans le cadre de marchés de fourniture de médicaments ou de dispositifs médicaux ?

Contenu apparenté

• 21/03/25

  China introduces long-awaited phar­ma­ceu­ti­cal trial data protection legislation

  On 19 March 2025, China’s National Medical Products Administration (NMPA) released a draft of the Implementing Measures for Pharmaceutical Trial Data Protection (for Trial Implementation), along with its accompanying implementation procedure, Working...
• 19/03/25

  Revolution in Patient Rights Protection: New Powers for the Commissioner for Patients' Rights and Stricter Penalties

  On March 10, 2025, new legislative proposals for amending the Act on Patient Rights and the Commissioner for Patients' Rights, as well as the Act on the emergency notification system, were added to the list of legislative works of the Council of Ministers....
• 31/01/25

  CMS Life Sciences Vital Signs Winter 2024/2025

  In our winter edition of Vital Signs we review how the new Labour Government in the UK aims to bring about significant changes to the life sciences & healthcare sector. We consider some key aspects of the party’s pre-election life sciences strategy...